Texas Children's neurosurgeon Dr. Daniel Curry leads the first-ever FDA-approved gene therapy treatment for AADC deficiency.
Texas Children’s is pleased to announce that a three-year-old girl has been successfully treated with the first-ever FDA-approved gene therapy treatment for AADC deficiency.
Read story in the Keymark Television Newsroom.
About the Author
